Walgreen’s Financing in Oklahoma
Low interest rates are available for Walgreen’s Financing store in Oklahoma. Seeking loans for 1031 Exchange NNN properties for commercial real estate investing be sure to contact our office for the loan terms to fit your criteria. We post sample commercial real estate interest rates daily on our web site.
Our loan products are from insurance companies, Wall Street Firms and Specialty Banks. Our insurance company lenders are most often looking for long term fixed interest rates up to 25-years. If you are considering an investment in triple net lease properties call or email us for a free no obligation loan quote.
Credit Tenant Lease Financing
Walgreen’s is rated by Standard & Poors as BBB and by Moody’s Baa2. Both of these credit rating fall within the investment grade criteria used in originating credit tenant leased loans also known as CTL financing. This type of structure can provide higher leverage than a traditional loan. The Cap Rates for Walgreen’s stores can vary widely. A Walgreen’s in a less populated area with less than 10-years left on the lease will generally have a higher Cap Rate than a well located store in a large community with 20-plus years remaining. For the most current SEC filing on Walgreen’s click here. We are happy to quickly provide you wit
1031 Exchange Walgreen’s Financing in Oklahoma
Are you coming out of a 1031 Exchange and considering Walgreen’s Financing Loganville GA store as the replacement property? Or perhaps you would like to know the financing options before submitting a formal offer to purchase? We have your solution, send us the realtors marketing package. Along with this realtors package outline the purchase price. Also provide the amount of loan you are seeking. We will need to know the intended time to hold the property. After this we can provide some loan options for you to consider. Also indicate if you wish to fully amortize the loan over the remaining lease period. Or if you prefer to consider a balloon balance. With this information we can provide you with financing solutions.
Balloon Balance
When considering a loan with a balloon balance the lender will assume the NNN tenant will not renew and the building will go dark at the end of the lease term. Therefore, take the time to try to estimate the value of the real estate at the end of the lease term, assuming the building is vacate (dark). This is the exercise the lender will go through. Do you need a simple Balloon Balance Excel Model? Just let us know and we can email this model to you.
Second Fiscal Quarter 2022 For Walgreen’s earnings summary:
DEERFIELD, Ill., March 31, 2022 – Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2022, which ended February 28, 2022.
Chief Executive Officer Rosalind Brewer said:
“Second quarter results demonstrated broad-based execution, driving strong comparable sales and robust earnings growth. We continue to make important strides along our strategic priorities, building a consumer-centric, technology-enabled healthcare enterprise at the center of local communities. VillageMD and Shields are delivering tremendous pro forma sales growth compared to their year-ago standalone results, and our Walgreens Health segment is on track toward long-term targets. The strategic review of our Boots business is progressing, and our transformational actions are accelerating sustainable value creation.”
Overview of Second Quarter Results
WBA second quarter sales from continuing operations increased 3.0 percent from the year-ago quarter to $33.8 billion, an increase of 3.8 percent on a constant currency basis. The performance reflects sales growth at Walgreens and in the International segment, and sales contributions from the Walgreens Health segment due to the recent acquisitions and consolidation of VillageMD and Shields, partly offset by a decline in sales at AllianceRx Walgreens.
Operating income from continuing operations was $1.2 billion in the second quarter compared to operating income of $832 million in the year-ago quarter. Adjusted operating income from continuing operations was $1.7 billion, an increase of 35.9 percent on a constant currency basis. The increases reflect strong adjusted gross profit growth across both pharmacy and retail in the United States and a continued rebound in International segment sales and profitability, partly offset by growth investments in Walgreens Health.
Net earnings from continuing operations were $883 million in the second quarter compared to $922 million in the year-ago quarter, reflecting robust operating performance offset by the company’s equity investments, including the lapping of a gain on the partial sale of the company’s equity method investment in Option Care Health in the year-ago quarter. Adjusted net earnings from continuing operations increased 25.8 percent to $1.4 billion, up 26.4 percent on a constant currency basis compared with the year-ago quarter.
EPS from continuing operations in the second quarter was $1.02 compared to EPS of $1.06 in the year-ago quarter. Adjusted EPS from continuing operations was $1.59, an increase of 25.9 percent on a reported basis and an increase of 26.5 percent on a constant currency basis.
Net cash provided by operating activities was $1.1 billion in the second quarter and free cash flow was $669 million, a $431 million decrease in free cash flow compared with the year-ago quarter primarily driven by phasing of working capital, repayment of COVID-19 related government support, and increased capital expenditures in growth initiatives, including rollout of new automated microfulfillment centers and the VillageMD footprint expansion.
Overview of Fiscal 2022 Year-to-Date Results for your review before buying a Walgreen’s to be financed:
Sales from continuing operations in the first six months of fiscal 2022 were $67.7 billion, an increase of 5.4 percent from the same period a year ago, and an increase of 5.7 percent on a constant currency basis, reflecting strong comparable sales growth at Walgreens and in the International segment.
Operating income from continuing operations in the first six months of fiscal 2022 was $2.5 billion compared to $298 million in the same period a year ago. This was partly driven by a $1.5 billion charge from the company’s equity earnings in AmerisourceBergen in the year-ago period. Adjusted operating income from continuing operations in the first six months of the fiscal year was $3.4 billion, an increase of 41.8 percent from the same period a year ago on a reported basis, and up 42.1 percent on a constant currency basis. The increases reflect strong adjusted gross profit growth across both pharmacy and retail in the United States and a continued rebound in International segment sales and profitability, partly offset by growth investments in Walgreens Health.
For the first six months of fiscal 2022, net earnings from continuing operations increased $3.9 billion compared to the same period a year earlier, to $4.5 billion, reflecting a $2.5 billion after-tax gain in the first quarter due to the valuation of the company’s previously held minority equity and debt investments in VillageMD and Shields, and the lapping of a $1.2 billion charge, net of tax, from the company’s equity earnings in AmerisourceBergen in the year-ago period. Adjusted net earnings from continuing operations increased 39.0 percent in constant currency to $2.8 billion.
EPS from continuing operations for the first six months of fiscal 2022 increased $4.54 to $5.15, compared to the same period a year ago. Adjusted EPS from continuing operations was $3.27, an increase of 38.6 percent on a reported basis and an increase of 38.8 percent on a constant currency basis.
Net cash provided by operating activities was $2.2 billion in the first six months of fiscal 2022, a decrease of $372 million from the same period last year, and free cash flow was $1.3 billion, a decrease of $550 million from the same period a year ago driven by the decline of the AllianceRx Walgreens business, phasing of working capital and increased capital expenditures in growth initiatives, including rollout of new automated microfulfillment centers and the VillageMD footprint expansion.
Contact: Mike Caffrey; [email protected]; www.CaffreyLoans.com
On our web site you can read about specific loan products: www.caffreyloans.com/loan-products, offered by Freddie Mac, Fannie Mae, HUD/FHA, Commercial Mortgage Back Securities (CMBS) and other loan products. Want more details on sample interest rates for apartment check out Interest Rates for Apartment Loans also on our web site: www.caffreyloans.com/apartment-loans.
Have a question please contact
Mike Caffrey
Telephone: (913) 402-7077
[email protected]
LinkedIn